NCT06501391 2024-08-28
Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis
Fudan University
Phase 2 Recruiting
Clinical Trials
6 trialsNCT04291092 2021-09-10
Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT01567202 2020-09-09
Study of DC Vaccination Against Glioblastoma
Huashan Hospital
Phase 2 Unknown
NCT00798811 2020-03-19
High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors
Samsung Medical Center
Phase 2 Unknown
NCT02425072 2017-08-10
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Phase 2 Withdrawn
NCT00002639 2013-06-21
Suramin in Treating Patients With Recurrent Primary Brain Tumors
National Cancer Institute (NCI)
Phase 2 Completed